Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Irbesartan And Hydrochlorothiazide (C09Da24) Within The Framework Of A So-Called Open-House Model.

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 90314102

  Document Type - Tender Notices

Description - Description: Conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient irbesartan and hydrochlorothiazide (C09DA24) within the period fro m October 1, 2024 to September 30, 2026 with the possibility of concluding the contract at any time (open-house model). In the open house procedure, medicinal products in accordance with the BfArM list according to Section 35 Paragraph 5a SGB V (medicines for children) are excluded.dispatch_date: 2024-08-05 00:00:00.000000 UTClocal title:: Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit d

Mt Ref Id - 90314102

Deadline - Jul 31, 2026